Company News
Agios Leads TD Cowen Pick on Thalassemia
TD Cowen analyst Marc Frahm names Agios Pharmaceuticals as top biotech recommendation, citing strong thalassemia franchise and pipeline progress.
Phase 3 RISE-UP sickle cell data showed a 0.77 g/dL he
